Immuno Cure is a clinical stage biotechnology group based in the Hong Kong Science Park, focusing on research and development of immunotherapies for cancers, inflammatory and infectious diseases based ...
"Palleon Pharmaceuticals reports Phase I/II trial results of E-602 for solid tumours" was originally created and published by ...
The largest ever clinical trial of T cell therapy for solid tumors has ended, heralding a new era for precision T cell ...
Ventus Therapeutics, a clinical-stage biopharmaceutical company utilizing its proprietary ReSOLVE™ platform to discover and ...
The shocking failure of AbbVie’s emraclidine has investors questioning the Big Pharma’s long-term neuroscience strategy, ...
“The Phase 1 clinical trial is designed to evaluate the safety, reactogenicity, and immunogenicity of ARCT-2304 as a potential vaccine to protect against the highly pathogenic H5N1 avian influenza.” ...
Following the clearance of an investigational new drug application from the FDA, a phase 1 trial will examine the novel ...
GlobalData on MSN5d
Zymeworks doses first subject in Phase I trial of ZW191 for solid tumoursZymeworks has dosed the first patient in its Phase I clinical trial of ZW191, an investigational therapy, aimed at treating ...
Wong and Ho and the team at MSKCC,” said Mark Winderlich, PhD, Chief Research and ... Our eseba-vec clinical development ...
Yet, AbbVie’s emraclidine has floundered where Karuna prospered. AbbVie’s phase 2 trials tested emraclidine as a once-daily, oral monotherapy in adults with schizophrenia experiencing an acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback